Use of Potentially Manipulative Communication Practices in Surrogate Decision-Making for Patients with COVID-19
This activity has been archived and credit is no longer available.
This is the inaugural session of the new joint Bioethics Grand Rounds series presented by the Texas Medical Center institutions Baylor College of Medicine, Baylor-St. Lukes Hospital, and Methodist Hospital. In this audio presentation, panelists Dr. Laura Kolbe, Dr. Ryan Nelson, Dr. Joelle Robertson-Preidler, and Dr. Olivia Schuman discuss the ethical considerations of communication with surrogate decision-makers during the COVID-19 Pandemic. They review their research based on real cases seen in practice and they share strategies to avoid using manipulative language or visuals when speaking with a patient's medical decision-makers.
This Bioethics Grand Rounds session took place on Wednesday, March 30, 2022 at 12:00 P.M. and has been approved for Ethics Credit.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Staff physicians and other allied health professionals need to be regularly updated on the guidelines and challenges related to ethics consultation, clinical ethics practice and the role of ethics in shared clinical decision-making. The series aims to increase knowledge of the learners in these topic areas, and to provide the skills and tools for their implementation in clinical practice in order to enhance the quality of patient care.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Evaluate how showing a patient's body to surrogates could potentially manipulate the goals of care decisions at the end of life.
- Explore how their senses might affect the rational decision-making of surrogates.
- Identify ethical ways of showing a patient's body to surrogates to inform decisions without unduly influencing or manipulating them.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Infectious Disease
Interest Groups
- COVID
- Ethics
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1.0 credit of education in medical ethics and/or professional responsibility.
Activity Director
Term of Approval
March 1, 2022 through March 31, 2024. Original release date: March 1, 2022.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Laura Kolbe, M.D.
Assistant Professor, Clinical Ethics Consultant
Weill Cornell Medical College
Disclosure:
Nothing to disclose.
-
Ryan Nelson, Ph.D., HEC-C
Assistant Professor
Center for Medical Ethics and Health Policy, Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Joelle Robertson-Preidler, Ph.D.
Clinical Ethics Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Olivia Schuman, Ph.D.
Clinical Ethics Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Savitri Fedson, M.D., M.A.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Andrew Childress, Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Savitri Fedson, M.D., M.A.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
David Garvis, Ph.D.
Clinical Ethicist
Baylor St. Luke’s Medical Center
Disclosure:
Nothing to disclose.
-
Claire Horner, J.D., M.A.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.